Extreme heat, precipitation linked to more severe asthma requiring hospitalization – Science Daily

Extreme heat, precipitation linked to more severe asthma requiring hospitalization
Science Daily
Based on over a decade of asthma hospitalization data (115,923 cases from 2000-2012), researchers observed higher risk of asthma hospitalization after extreme heat or extreme precipitation events. The increases in risk were particularly high during

and more »

View full post on asthma – Google News

Extreme heat and precipitation linked to more severe asthma requiring hospitalization – Medical Xpress


Medical Xpress

Extreme heat and precipitation linked to more severe asthma requiring hospitalization
Medical Xpress
Based on over a decade of asthma hospitalization data (115,923 cases from 2000-2012), researchers observed higher risk of asthma hospitalization after extreme heat or extreme precipitation events. The increases in risk were particularly high during

and more »

View full post on asthma – Google News

Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

Condition:   Asthma
Interventions:   Drug: Respimat® Budesonide low dose;   Drug: Respimat® Budesonide high dose;   Drug: Turbohaler® Budesonide;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Completed – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days